HRP980037B1 - Method of making (1s, 4r)-1-azabicyclo/2.2.1/heptan-3-one and (1r, 4s), 1-azabicyclo/2.2.1/heptan-3-one - Google Patents

Method of making (1s, 4r)-1-azabicyclo/2.2.1/heptan-3-one and (1r, 4s), 1-azabicyclo/2.2.1/heptan-3-one

Info

Publication number
HRP980037B1
HRP980037B1 HR980037A HRP980037A HRP980037B1 HR P980037 B1 HRP980037 B1 HR P980037B1 HR 980037 A HR980037 A HR 980037A HR P980037 A HRP980037 A HR P980037A HR P980037 B1 HRP980037 B1 HR P980037B1
Authority
HR
Croatia
Prior art keywords
heptan
azabicyclo
making
Prior art date
Application number
HR980037A
Other languages
English (en)
Inventor
Denis Martin Sobieray
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HRP980037A2 publication Critical patent/HRP980037A2/hr
Publication of HRP980037B1 publication Critical patent/HRP980037B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR980037A 1997-01-27 1998-01-12 Method of making (1s, 4r)-1-azabicyclo/2.2.1/heptan-3-one and (1r, 4s), 1-azabicyclo/2.2.1/heptan-3-one HRP980037B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3628597P 1997-01-27 1997-01-27

Publications (2)

Publication Number Publication Date
HRP980037A2 HRP980037A2 (en) 1998-10-31
HRP980037B1 true HRP980037B1 (en) 2002-04-30

Family

ID=21887726

Family Applications (1)

Application Number Title Priority Date Filing Date
HR980037A HRP980037B1 (en) 1997-01-27 1998-01-12 Method of making (1s, 4r)-1-azabicyclo/2.2.1/heptan-3-one and (1r, 4s), 1-azabicyclo/2.2.1/heptan-3-one

Country Status (27)

Country Link
US (1) US6121306A (ko)
EP (1) EP0968212B1 (ko)
JP (1) JP2001511133A (ko)
KR (1) KR20000070367A (ko)
AR (1) AR011574A1 (ko)
AT (1) ATE216391T1 (ko)
AU (1) AU728324B2 (ko)
BR (1) BR9807519A (ko)
CA (1) CA2269683A1 (ko)
CO (1) CO5031243A1 (ko)
DE (1) DE69804951T2 (ko)
DK (1) DK0968212T3 (ko)
ES (1) ES2176958T3 (ko)
GT (1) GT199800020A (ko)
HN (1) HN1998000013A (ko)
HR (1) HRP980037B1 (ko)
IL (1) IL129511A (ko)
MX (1) MXPA99003600A (ko)
NZ (1) NZ335782A (ko)
PA (1) PA8445501A1 (ko)
PE (1) PE57299A1 (ko)
PT (1) PT968212E (ko)
SV (1) SV1998000012A (ko)
TW (1) TW409126B (ko)
UY (1) UY24858A1 (ko)
WO (1) WO1998032759A1 (ko)
ZA (1) ZA98616B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1638937E (pt) * 2003-06-18 2009-01-27 Teva Pharma Forma xiv cristalina de fluvastatina sódica, processos para a sua preparação, composições que a contêm e métodos de utilização
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment

Also Published As

Publication number Publication date
NZ335782A (en) 2000-01-28
ZA98616B (en) 1998-10-23
DE69804951D1 (de) 2002-05-23
EP0968212A1 (en) 2000-01-05
IL129511A0 (en) 2000-02-29
HRP980037A2 (en) 1998-10-31
ATE216391T1 (de) 2002-05-15
PT968212E (pt) 2002-09-30
KR20000070367A (ko) 2000-11-25
ES2176958T3 (es) 2002-12-01
IL129511A (en) 2003-03-12
PE57299A1 (es) 1999-06-14
AR011574A1 (es) 2000-08-30
DE69804951T2 (de) 2003-04-24
PA8445501A1 (es) 2000-05-24
UY24858A1 (es) 1998-06-25
JP2001511133A (ja) 2001-08-07
CO5031243A1 (es) 2001-04-27
SV1998000012A (es) 1998-08-13
DK0968212T3 (da) 2002-07-22
MXPA99003600A (es) 2003-08-20
GT199800020A (es) 1999-07-20
AU728324B2 (en) 2001-01-04
BR9807519A (pt) 2000-03-21
WO1998032759A1 (en) 1998-07-30
CA2269683A1 (en) 1998-07-30
AU6041098A (en) 1998-08-18
HN1998000013A (es) 1999-12-01
US6121306A (en) 2000-09-19
EP0968212B1 (en) 2002-04-17
TW409126B (en) 2000-10-21

Similar Documents

Publication Publication Date Title
EP0648770A3 (de) Neue Pyrrolo 3,4-c pyrrole.
EP0620240A3 (en) Process for the production of (co) polycarbonates.
AU3295095A (en) Solid golf ball and process for producing the same
GB9504165D0 (en) Steering column locking assembly and method of making the same
ZA968386B (en) Amine capped polyethers and process for producing same.
EP0660152A3 (en) Dynamic aberration correction device for conformable windows.
EP0647134A4 (en) METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-).
SG43113A1 (en) Process for the preparation of lactam
CY2342B1 (en) Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1H-benz(de)isoquinolin-1-one and intermediate product.
AU6703394A (en) Method of treating depression using neurotrophins
EP0577253A3 (en) Enrichment of Quinuklidinolenantiomere.
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
HU9503678D0 (en) Quinuclidine and azabicyclo[2,2,1]-heptane-pyrazinyl-ethers as muscarinic agonists
HRP980037B1 (en) Method of making (1s, 4r)-1-azabicyclo/2.2.1/heptan-3-one and (1r, 4s), 1-azabicyclo/2.2.1/heptan-3-one
HUP9801083A3 (en) Process for producing (15,4r)- or (1r,4s)-4-[(2-amino-6-chloro-9h-purin)-9-yl]-2-cyclopentene-1-methanol
EP0622384A3 (de) Verfahren zur Herstellung von Polymerpolyesterolen.
ZA943316B (en) Process for the preparation of microballs and microballs thus obtained.
SI0968212T1 (en) Method of making (1s, 4r)-1-azabicyclo 2.2.1)heptan-3-one and (1r, 4s), 1-azabicyclo 2.2.1)heptan-3-one
EP0734091A3 (en) Window antenna for motor vehicles and method for designing such an antenna
EP0608745A3 (en) Method of manufacturing MOS components.
EP0635482A3 (de) Verfahren zur Herstellung von mehrfach fluorierten Nitrobenzolen.
EP0675146A4 (en) POLYDIOXOLANE WITH HIGH MOLECULAR WEIGHT AND PROCESS FOR PRODUCING THE SAME.
ZA975637B (en) Method for the treatment of emesis.
EP0663207A3 (en) Bamboo salt manufacturing process.
EP0611214A3 (en) Acid composition and method of use.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030108

Year of fee payment: 6

PBON Lapse due to non-payment of renewal fee

Effective date: 20040113